De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

Changes in the biosynthesis of fatty acids can influence tissue insulin sensitivity and the development of metabolic diseases. Eissing and colleagues show that de novo lipogenesis in liver and adipose tissue is linked to metabolic health in humans and can be modulated by bariatric surgery.